The local working group involves organisations and other key programmes in the health sector. It is envisaged that the ABR work would utilise existing health system to ensure buy-in and sustainability. Key partners in this endeavour will include:

1. MoH/GHS – Providing leadership and overall policy direction

2. GNDP – Experiences in project management and developing policies in a multistakeholder environment. It has coordinated a number of projects including BMC, MeTA, NDP, STG and the EML

3. FDB- Regulatory body in charge of product registration quality assurance and post marketing surveillance. They are important when it comes to quality of antibiotics on the Ghanaian market.

4. Universities – Research and capacity building support. The vision is to see the University of Ghana microbiology department, NMIMR, and KNUST having joint research, postgraduate or doctoral programmes to build capacity.

5. WHO – Providing programme support, funding and technical direction at the regions

6. ADMER Project – Already in ABR research. Also involved in capacity building and data generation

7. PMAG – Strategic in keeping quality control and quality assurance of antimicrobials produced by their membership

8. INDEPTH – Involved in demographic surveillance. Strategic in building on their existing structures to conduct surveillance on antibiotics

9. Professional bodies – Professional and political direction for this project

10. CSOs – Community entry, to capture the general public and for advocacy

11. Veterinary Practitioners Association - To handle animal aspects of the ABR activity

12. Media persons – important to carry the message on ABR forward.

Ghana National Drugs Programme, Ministry of Health (GNDP MOH) 2015